
Jared Barsky
Examiner (ID: 7259, Phone: (571)272-2795 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1628 |
| Total Applications | 1117 |
| Issued Applications | 492 |
| Pending Applications | 146 |
| Abandoned Applications | 503 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13687389
[patent_doc_number] => 20170354649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => THERAPEUTIC USES OF BERBERINE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 15/681950
[patent_app_country] => US
[patent_app_date] => 2017-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15681950
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/681950 | Therapeutic uses of berberine formulations | Aug 20, 2017 | Issued |
Array
(
[id] => 17256690
[patent_doc_number] => 20210369675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => ANTIMICROBIAL DRUG METHODS OF USE & THERAPEUTIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/326433
[patent_app_country] => US
[patent_app_date] => 2017-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7915
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326433
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/326433 | ANTIMICROBIAL DRUG METHODS OF USE & THERAPEUTIC COMPOSITIONS | Aug 18, 2017 | Abandoned |
Array
(
[id] => 14403611
[patent_doc_number] => 20190167649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => TOPICAL RAPAMYCIN THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/324274
[patent_app_country] => US
[patent_app_date] => 2017-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6602
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16324274
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/324274 | TOPICAL RAPAMYCIN THERAPY | Aug 9, 2017 | Abandoned |
Array
(
[id] => 12702034
[patent_doc_number] => 20180125844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => TREATMENT OF RELAPSED AND/OR REFRACTORY SOLID TUMORS AND NON-HODGKIN'S LYMPHOMAS
[patent_app_type] => utility
[patent_app_number] => 15/673084
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673084
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/673084 | Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas | Aug 8, 2017 | Issued |
Array
(
[id] => 16491093
[patent_doc_number] => 10857110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Antibacterial compounds
[patent_app_type] => utility
[patent_app_number] => 16/324509
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4388
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16324509
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/324509 | Antibacterial compounds | Aug 8, 2017 | Issued |
Array
(
[id] => 13898865
[patent_doc_number] => 20190038637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => Use of Hydroxyprogesterone Derivatives for Enhanced Health and Physical Performance II
[patent_app_type] => utility
[patent_app_number] => 15/669909
[patent_app_country] => US
[patent_app_date] => 2017-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15669909
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/669909 | Use of Hydroxyprogesterone Derivatives for Enhanced Health and Physical Performance II | Aug 4, 2017 | Abandoned |
Array
(
[id] => 14682117
[patent_doc_number] => 20190240173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => NEW USE OF N,N-BIS-2-MERCAPTOETHYL ISOPHTHALAMIDE
[patent_app_type] => utility
[patent_app_number] => 16/318842
[patent_app_country] => US
[patent_app_date] => 2017-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318842
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318842 | NEW USE OF N,N-BIS-2-MERCAPTOETHYL ISOPHTHALAMIDE | Aug 3, 2017 | Abandoned |
Array
(
[id] => 13699633
[patent_doc_number] => 20170360771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => TREATING POSTOPERATIVE NAUSEA AND VOMITING
[patent_app_type] => utility
[patent_app_number] => 15/666889
[patent_app_country] => US
[patent_app_date] => 2017-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5362
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15666889
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/666889 | TREATING POSTOPERATIVE NAUSEA AND VOMITING | Aug 1, 2017 | Abandoned |
Array
(
[id] => 12259375
[patent_doc_number] => 20180078570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'TETRACYCLINE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 15/660698
[patent_app_country] => US
[patent_app_date] => 2017-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20041
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15660698
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/660698 | TETRACYCLINE COMPOSITIONS | Jul 25, 2017 | Abandoned |
Array
(
[id] => 12030711
[patent_doc_number] => 20170320810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-09
[patent_title] => 'NOVEL ASPIRIN DERIVATIVES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/660032
[patent_app_country] => US
[patent_app_date] => 2017-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 28697
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15660032
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/660032 | Aspirin derivatives and uses thereof | Jul 25, 2017 | Issued |
Array
(
[id] => 12904411
[patent_doc_number] => 20180193312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => NUTRACEUTICAL COMPOSITION AND DOSING REGIMEN
[patent_app_type] => utility
[patent_app_number] => 15/658719
[patent_app_country] => US
[patent_app_date] => 2017-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15658719
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/658719 | NUTRACEUTICAL COMPOSITION AND DOSING REGIMEN | Jul 24, 2017 | Abandoned |
Array
(
[id] => 15946019
[patent_doc_number] => 10660887
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-26
[patent_title] => Composition and method for treatment of depression and psychosis in humans
[patent_app_type] => utility
[patent_app_number] => 15/650912
[patent_app_country] => US
[patent_app_date] => 2017-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7728
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15650912
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/650912 | Composition and method for treatment of depression and psychosis in humans | Jul 15, 2017 | Issued |
Array
(
[id] => 12254185
[patent_doc_number] => 09926322
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-27
[patent_title] => 'Purinone derivative'
[patent_app_type] => utility
[patent_app_number] => 15/648941
[patent_app_country] => US
[patent_app_date] => 2017-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25012
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15648941
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/648941 | Purinone derivative | Jul 12, 2017 | Issued |
Array
(
[id] => 14535263
[patent_doc_number] => 20190203253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => METHODS OF IDENTIFYING AND TREATING CANCER PATIENTS WITH AN EPHB6 DEFICIENCY
[patent_app_type] => utility
[patent_app_number] => 16/312410
[patent_app_country] => US
[patent_app_date] => 2017-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312410
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312410 | METHODS OF IDENTIFYING AND TREATING CANCER PATIENTS WITH AN EPHB6 DEFICIENCY | Jul 4, 2017 | Abandoned |
Array
(
[id] => 11986612
[patent_doc_number] => 20170290766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-12
[patent_title] => 'SOFT CHEWABLE PHARMACEUTICAL PRODUCTS'
[patent_app_type] => utility
[patent_app_number] => 15/634924
[patent_app_country] => US
[patent_app_date] => 2017-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9651
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15634924
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/634924 | Soft chewable pharmaceutical products | Jun 26, 2017 | Issued |
Array
(
[id] => 12790531
[patent_doc_number] => 20180155346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
[patent_app_type] => utility
[patent_app_number] => 15/633477
[patent_app_country] => US
[patent_app_date] => 2017-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 85048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15633477
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/633477 | Compounds useful as inhibitors of ATR kinase | Jun 25, 2017 | Issued |
Array
(
[id] => 11977353
[patent_doc_number] => 20170281506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'COMPOSITION FOR TOPICAL APPLICATION FOR PREVENTING HAIR LOSS AND STIMULATING HAIR GROWTH'
[patent_app_type] => utility
[patent_app_number] => 15/631766
[patent_app_country] => US
[patent_app_date] => 2017-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6824
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15631766
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/631766 | COMPOSITION FOR TOPICAL APPLICATION FOR PREVENTING HAIR LOSS AND STIMULATING HAIR GROWTH | Jun 22, 2017 | Abandoned |
Array
(
[id] => 17799020
[patent_doc_number] => 11413286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Producing astrocytes using small molecules
[patent_app_type] => utility
[patent_app_number] => 16/311965
[patent_app_country] => US
[patent_app_date] => 2017-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 24
[patent_no_of_words] => 11896
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311965
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311965 | Producing astrocytes using small molecules | Jun 20, 2017 | Issued |
Array
(
[id] => 14774891
[patent_doc_number] => 20190262343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => WOUND HEALING USING BRAF INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/312893
[patent_app_country] => US
[patent_app_date] => 2017-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16223
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312893
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312893 | WOUND HEALING USING BRAF INHIBITORS | Jun 20, 2017 | Abandoned |
Array
(
[id] => 13179747
[patent_doc_number] => 10105361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-23
[patent_title] => Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
[patent_app_type] => utility
[patent_app_number] => 15/621882
[patent_app_country] => US
[patent_app_date] => 2017-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 44468
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15621882
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/621882 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Jun 12, 2017 | Issued |